824932-90-3Relevant articles and documents
PYRROLIDINE DERIVATIVES AS PPAR AGONISTS
-
Paragraph 0125; 0128; 0129, (2019/08/02)
The present invention discloses a class of pyrrolidine derivatives as PPAR agonist, and their use for the treatment of some diseases of PPAR receptor-associated pathways (such as nonalcoholic steatohepatitis and concurrent fibrosis, insulin resistance, primary biliary cholgangitis, dyslipidenmia, hyperlipidemia, hypercholesterolemia, atherosclerosis, hypertriglyceridemia, cardiovascular disease, obesity or the like). In particular, the present invention discloses a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof.
IMPROVED PREPARATION OF CHALCONE DERIVATIVES
-
Page/Page column 24-25, (2011/12/04)
The invention relates to methods for producing chalcone (1,3-diphenylprop-2-en-1 -one) derivatives that have multiple substitutions on a phenyl ring. Intermediate chalcone derivatives are modified by Phase Transfer Catalysis (PTC) for introducing a substi